DUBLIN–(BUSINESS WIRE)–The “Injectable Drug Delivery Devices – Medical Devices Pipeline Assessment, 2020” report has been added to ResearchAndMarkets.com’s offering.
“Injectable Drug Delivery Devices – Medical Devices Pipeline Assessment, 2020”. Injectable Drug Delivery Devices are defined as administration of a drug into patient’s blood through a delivery device.
Scope
- Extensive coverage of the Injectable Drug Delivery Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Injectable Drug Delivery Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Injectable Drug Delivery Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Key Topics Covered:
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Injectable Drug Delivery Overview
3 Products under Development
3.1 Injectable Drug Delivery – Pipeline Products by Stage of Development
3.2 Injectable Drug Delivery – Pipeline Products by Segment
3.3 Injectable Drug Delivery – Pipeline Products by Territory
3.4 Injectable Drug Delivery – Pipeline Products by Regulatory Path
3.5 Injectable Drug Delivery – Pipeline Products by Estimated Approval Date
3.6 Injectable Drug Delivery – Ongoing Clinical Trials
4 Injectable Drug Delivery – Pipeline Products under Development by Companies
4.1 Injectable Drug Delivery Companies – Pipeline Products by Stage of Development
4.2 Injectable Drug Delivery – Pipeline Products by Stage of Development
5 Injectable Drug Delivery Companies and Product Overview
6 Injectable Drug Delivery- Recent Developments 2137 Appendix
7 Appendix
Companies Mentioned
- Adalvo
- Adamis Pharmaceuticals Corp
- AdrenaCard, Inc.
- AktiVax Inc.
- Allergan Ltd
- Alsensa ApS
- Antares Pharma Inc
- Aquavit Pharmaceuticals Inc
- Artemes Technologies, Inc.
- Ascendis Pharma A/S
- ASCIL Biopharm
- ASIS Corp
- AzureBio SL
- Bespak Europe Ltd
- Biocorp Production SA
- 1BioCorRx Inc
- BioRestorative Therapies Inc
- Bioxis Pharmaceuticals
- Brigham and Women’s Hospital
- Burke Pharmaceuticals LLC
- Calla Health Foundation
- Callisyn Biomedical Inc
- Cambridge Consultants Ltd
- Camurus AB
- Case Western Reserve University
- Cincinnati Children’s Hospital Medical Center
- Clearside BioMedical Inc
- DALI Medical Devices Ltd.
- DelSite, Inc. (Inactive)
- Drexel University
- Duoject Medical Systems Inc
- Ecole Polytechnique Federale de Lausanne
- Elcam Medical
- EmboMedics Inc
- Embryyo Technologies Pvt Ltd
- Emergent BioSolutions Inc
- EP Global Communications Inc (Inactive)
- Eveon SAS
- EyePoint Pharmaceuticals Inc
- FHC Inc
- GeneSYS-ID Inc
- Georgia Institute of Technology
- Ghent University
- Globe Medical Tech Inc (Inactive)
- Hoffmann-La Roche Inc
- Inovio Pharmaceuticals Inc
- InVivo Therapeutics Corp
- Ionic Pharmaceuticals LLC
- JCR Pharmaceuticals Co Ltd
- komarik
- Kyowa Kirin Ltd
- Lohmann Therapie-Systeme AG
- 5LyoGo
- Mallinckrodt Plc
- Mercator MedSystems Inc
- Mertiva AB
- Midas Pharma GmbH
- Milestone Scientific Inc
- 5Millendo Therapeutics Inc
- Morimoto Pharma Co Ltd
- NanoPass Technologies Ltd
- Novo Nordisk AS
- Novosanis NV
- Osteo Pharma BV
- Oval Medical Technologies Ltd
- Owen Mumford Ltd
- Palatin Technologies Inc
- Particle Therapeutics Ltd
- Portal Instruments Inc
- Prohibix LLC
- QuiO Technologies LLC
- Regeneron Pharmaceuticals Inc
- RepliCel Life Sciences Inc
- Rescitech Vision Pvt Ltd
- RetinaPharma Technologies Inc
- Sapporo Medical University School of Medicine
- Schott AG
- Subcuject ApS
- Sunshine Guojian Pharmaceutical Shanghai Co Ltd
- Takeda Pharmaceutical Co Ltd
- TCB medical devices
- Terumo Corp
- Teva Pharmaceutical Industries Ltd
- TheraKine Inc (Inactive)
- Twin Star Medical Inc
- Unilife Corporation
- University of Calgary
- University of California San Diego
- University of California San Francisco
- University of Delaware
- University of Dundee
- University of Florida
- University of New Mexico
- University of Saskatchewan
- University of Texas at Austin
- Vanderbilt University
- West Pharmaceutical Services Inc
- Windgap Medical Inc
- XERIS Pharmaceuticals Inc
- Ypsomed Holding AG
- Zosano Pharma Corp
For more information about this report visit https://www.researchandmarkets.com/r/pdw4og
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900